For: | Jain S, Singhal S, Francis F, Hajdu C, Wang JH, Suriawinata A, Wang YQ, Zhang M, Weinshel EH, Francois F, Pei ZH, Lee P, Xu RL. Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma. World J Gastroenterol 2011; 17(35): 3994-4000 [PMID: 22046087 DOI: 10.3748/wjg.v17.i35.3994] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i35/3994.htm |
Number | Citing Articles |
1 |
Michael A. Mandell, Bhaskar Saha, Todd A. Thompson. The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00308
|
2 |
Fengfeng Cai, Lu Cai, Zhuchao Zhou, Xin Pan, Minghong Wang, Su Chen, Manuel Luis, Chunmei Cen, Ewelina Biskup. Prognostic role of Tif1γ expression and circulating tumor cells in patients with breast cancer. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10033
|
3 |
Angelika Lackner, Viktoria Tiefenthaler, Jalia Mirzayeva, Florian Posch, Christopher Rossmann, Kastriot Kastrati, Helga Radner, Ulrike Demel, Judith Gretler, Michael Stotz, Winfried B Graninger, Martin H Stradner. The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective study. Therapeutic Advances in Musculoskeletal Disease 2020; 12 doi: 10.1177/1759720X20975907
|
4 |
Payam Mohassel, Paul Rosen, Livia Casciola‐Rosen, Katherine Pak, Andrew L. Mammen. Expression of the Dermatomyositis Autoantigen Transcription Intermediary Factor 1γ in Regenerating Muscle. Arthritis & Rheumatology 2015; 67(1): 266 doi: 10.1002/art.38863
|
5 |
Loay Kassem, Mathieu Deygas, Laurent Fattet, Jonathan Lopez, Thibaut Goulvent, Emilie Lavergne, Sylvie Chabaud, Nicolas Carrabin, Nicolas Chopin, Thomas Bachelot, Germain Gillet, Isabelle Treilleux, Ruth Rimokh. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1471-y
|
6 |
Bianca A. Romo, Barbara Karakyriakou, Lauren Cressey, Brooke L. Brauer, Huijuan Yang, Alexa Warren, Anneka L. Johnson, Arminja N. Kettenbach, Todd W. Miller. TRIM33 Is a Co-Regulator of Estrogen Receptor Alpha. Cancers 2024; 16(5): 845 doi: 10.3390/cancers16050845
|
7 |
Roisin M. McAvera, Lisa J. Crawford. TIF1 Proteins in Genome Stability and Cancer. Cancers 2020; 12(8): 2094 doi: 10.3390/cancers12082094
|
8 |
Marie-Lorraine Chrétien, Caroline Legouge, Romain Z. Martin, Arlette Hammann, Malika Trad, Romain Aucagne, Anne Largeot, Jean-Noël Bastie, Laurent Delva, Ronan Quéré. Trim33/Tif1γ is involved in late stages of granulomonopoiesis in mice. Experimental Hematology 2016; 44(8): 727 doi: 10.1016/j.exphem.2016.04.009
|
9 |
Kohei Karino, Yuichiro Fujieda, Takuya Kawamura, Nobuya Abe, Shuhei Shimoyama, Michihito Kono, Masaru Kato, Shinsuke Yasuda, Tatsuya Atsumi. Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an “autoimmune tumor marker”. Medicine 2018; 97(49): e13563 doi: 10.1097/MD.0000000000013563
|
10 |
Young Kim, Kyu Sang Song, Eun Hee Sohn, Seong Wook Kang, In Seol Yoo, Seung‐Cheol Shim, Su‐Jin Yoo, Jinhyun Kim. Anti‐TIF1γ antibody and the expression of TIF1γ in idiopathic inflammatory myopathies. International Journal of Rheumatic Diseases 2019; 22(2): 314 doi: 10.1111/1756-185X.13424
|
11 |
Seung-Yeon Yoo, Ji-Ae Lee, Yunjoo Shin, Nam-Yun Cho, Jeong Mo Bae, Gyeong Hoon Kang. Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma. Journal of Pathology and Translational Medicine 2019; 53(5): 289 doi: 10.4132/jptm.2019.06.07
|
12 |
Audrey Aussy, Manuel Fréret, Laure Gallay, Didier Bessis, Thierry Vincent, Denis Jullien, Laurent Drouot, Fabienne Jouen, Pascal Joly, Isabelle Marie, Alain Meyer, Jean Sibilia, Brigitte Bader‐Meunier, Eric Hachulla, Mohammed Hamidou, Sophie Huë, Jean‐Luc Charuel, Nicole Fabien, Pierre‐Julien Viailly, Yves Allenbach, Olivier Benveniste, Nadège Cordel, Olivier Boyer. The IgG2 Isotype of Anti–Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis. Arthritis & Rheumatology 2019; 71(8): 1360 doi: 10.1002/art.40895
|
13 |
Julie De Vooght, Jean-Baptiste Vulsteke, Petra De Haes, Xavier Bossuyt, Rik Lories, Ellen De Langhe. Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigen. Rheumatology 2020; 59(3): 469 doi: 10.1093/rheumatology/kez572
|
14 |
Choon-Guan Chua, Jia-Zhen Low, Wei-Yen Lim, Mona Manghani. Characteristics of anti-transcriptional intermediary factor 1 gamma autoantibody-positive dermatomyositis patients in Singapore. Annals of the Academy of Medicine, Singapore 2022; 51(12): 755 doi: 10.47102/annals-acadmedsg.2022278
|
15 |
Ran Nakashima. 4. Polymyositis and Dermatomyositis. Nihon Naika Gakkai Zasshi 2014; 103(10): 2487 doi: 10.2169/naika.103.2487
|
16 |
Rossella Talotta. Sequence Alignment between TRIM33 Gene and Human Noncoding RNAs: A Potential Explanation for Paraneoplastic Dermatomyositis. Journal of Personalized Medicine 2024; 14(6): 628 doi: 10.3390/jpm14060628
|
17 |
Chengpeng Yu, Zeyang Ding, Huifang Liang, Bixiang Zhang, Xiaoping Chen. The Roles of TIF1γ in Cancer. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00979
|
18 |
Cédric Hesling, Jonathan Lopez, Laurent Fattet, Philippe Gonzalo, Isabelle Treilleux, Daphné Blanchard, Régine Losson, Vincent Goffin, Natascha Pigat, Alain Puisieux, Ivan Mikaelian, Germain Gillet, Ruth Rimokh. Tif1γ is essential for the terminal differentiation of mammary alveolar epithelial cells and for lactation through SMAD4 inhibition. Development 2013; 140(1): 167 doi: 10.1242/dev.085068
|
19 |
Anastasia Slobodnick, Svetlana Krasnokutsky, Robert A. Lehmann, Robert T. Keenan, Jonathan Quach, Fritz Francois, Michael H. Pillinger. Colorectal Cancer Among Gout Patients Undergoing Colonoscopy. JCR: Journal of Clinical Rheumatology 2019; 25(8): 335 doi: 10.1097/RHU.0000000000000893
|
20 |
Audrey Aussy, Olivier Boyer, Nadège Cordel. Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00992
|
21 |
Xinbao Yin, Chuanshen Xu, Xueping Zheng, Huiyang Yuan, Ming Liu, Yue Qiu, Jun Chen. SnoN suppresses TGF-β-induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1γ-dependent manner. Oncology Reports 2016; 36(3): 1535 doi: 10.3892/or.2016.4939
|
22 |
Ze-yang Ding, Guan-nan Jin, Wei Wang, Wei-xun Chen, Yan-hui Wu, Xi Ai, Lin Chen, Wan-guang Zhang, Hui-fang Liang, Arian Laurence, Ming-zhi Zhang, Pran K. Datta, Bixiang Zhang, Xiao-ping Chen. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Hepatology 2014; 60(5): 1620 doi: 10.1002/hep.27273
|
23 |
Liubing Li, Chenxi Liu, Qian Wang, Chanyuan Wu, Yanfang Zhang, Linlin Cheng, Xiaoting Wen, Xiaofeng Zeng, Fengchun Zhang, Yongzhe Li. Analysis of myositis autoantibodies in Chinese patients with cancer‐associated myositis. Journal of Clinical Laboratory Analysis 2020; 34(8) doi: 10.1002/jcla.23307
|
24 |
Ayan Chanda, Angela Chan, Lili Deng, Elizabeth N. Kornaga, Emeka K. Enwere, Donald G. Morris, Shirin Bonni, Irina U Agoulnik. Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer. PLOS ONE 2017; 12(5): e0177639 doi: 10.1371/journal.pone.0177639
|
25 |
Ryoko Sakamoto, Ikko Kajihara, Hitomi Miyauchi, Saki Maeda-Otsuka, Saori Yamada-Kanazawa, Soichiro Sawamura, Hisashi Kanemaru, Katsunari Makino, Jun Aoi, Takamitsu Makino, Satoshi Fukushima, Mamiko Masuzawa, Mikio Masuzawa, Yasuyuki Amoh, Daichi Hoshina, Riichiro Abe, Hironobu Ihn. Inhibition of Endoglin Exerts Antitumor Effects through the Regulation of Non-Smad TGF-β Signaling in Angiosarcoma. Journal of Investigative Dermatology 2020; 140(10): 2060 doi: 10.1016/j.jid.2020.01.031
|
26 |
Sei‐ichiro Motegi, Akiko Sekiguchi, Hidekazu Ikeuchi, Toru Sakairi, Hiroomi Ogawa, Takaaki Fujii, Makoto Sohda, Toshiki Yajima, Shota Ida, Yukihiro Takayasu, Yuki Shimoda, Keiju Hiromura, Hiroshi Saeki, Ken Shirabe, Kazuaki Chikamatsu, Hideaki Yokoo, Tetsunari Oyama, Osamu Ishikawa. Clinical features of anti‐transcription intermediary factor 1γ (TIF1γ)‐positive dermatomyositis with internal malignancy and investigation of the involvement of TIF1γ expression in tumors in the pathogenesis of cancer‐associated dermatomyositis. The Journal of Dermatology 2020; 47(12): 1395 doi: 10.1111/1346-8138.15526
|
27 |
Yanhui Wu, Bin Yu, Xi Ai, Wei Zhang, Weixun Chen, Arian Laurence, Mingzhi Zhang, Qian Chen, Yajie Shao, Bixiang Zhang. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis. Biological Chemistry 2024; 405(4): 241 doi: 10.1515/hsz-2023-0233
|
28 |
Tian Xia, Lian Meng, Guixuan Xu, Hao Sun, Hao Chen. TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth. Cell Death & Disease 2024; 15(10) doi: 10.1038/s41419-024-07137-z
|